GenOway Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Public

  • Employees
  • 163

Employees

  • Stock Symbol
  • ALGEN

Stock Symbol

  • Investments
  • 6

  • Share Price
  • $2.09
  • (As of Friday Closing)

GenOway General Information

Description

Genoway SA specializes in genetic designs to serve genetically modified (GM) mice, rat and cell lines for the biopharmaceutical industries and research industries.

Contact Information

Website
www.genoway.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 31 Rue Saint Jean de Dieu
  • 69007 Lyon
  • France
Primary Industry
Biotechnology
Stock Exchange
PAR
Corporate Office
  • 31 Rue Saint Jean de Dieu
  • 69007 Lyon
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GenOway Stock Performance

As of 20-Nov-2026, GenOway’s stock price is $2.09. Its current market cap is $25.8M with 12.3M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.09 $2.14 $1.97 - $3.39 $25.8M 12.3M 8.96K -$0.17

GenOway Financials Summary

As of 30-Jun-2026, GenOway has a trailing 12-month revenue of $23.1M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 41,064 53,025 37,312 47,520
Revenue 23,067 23,639 23,870 21,692
EBITDA 2,655 5,570 5,543 6,837
Net Income (2,446) 1,047 1,981 1,696
Total Assets 52,386 53,274 33,090 35,199
Total Debt 17,380 16,175 5,802 7,996
Public Fundamental Data provided by Morningstar, Inc. disclaimer

GenOway Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GenOway‘s full profile, request access.

Request a free trial

GenOway Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Genoway SA specializes in genetic designs to serve genetically modified (GM) mice, rat and cell lines for the biopharmac
Biotechnology
Lyon, France
163 As of 2026

Torrance, CA

Somerville, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GenOway Competitors (32)

One of GenOway’s 32 competitors is Celprogen, a Private Debt Financed company based in Torrance, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Celprogen Private Debt Financed Torrance, CA
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
Premas Biotech Venture Capital-Backed Gurugram, India
GemPharmatech Formerly VC-backed Nanjing, China
Lake Immunogenics Private Debt Financed Ontario, NY
You’re viewing 5 of 32 competitors. Get the full list »

GenOway Patents

GenOway Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-1814998-A2 Animal models comprising at least one conditional ko and one conditional ki Active 08-Nov-2004
EP-1814998-B1 Animal models comprising at least one conditional ko and one conditional ki Inactive 08-Nov-2004
US-20090062477-A1 Animal models comprising at least one conditional ko and one conditional ki Inactive 08-Nov-2004
WO-2006048466-A2 Animal models comprising at least one conditional ko and one conditional ki Inactive 08-Nov-2004
WO-2006048466-A3 Animal models comprising at least one conditional ko and one conditional ki Inactive 08-Nov-2004 C12N15/8509
To view GenOway’s complete patent history, request access »

GenOway Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GenOway Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GenOway‘s full profile, request access.

Request a free trial

GenOway Investments & Acquisitions (6)

GenOway’s most recent deal was a Corporate Asset Purchase with OMICS Platform (Data Science and AI Assets) for . The deal was made on 16-Dec-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
OMICS Platform (Data Science and AI Assets) 16-Dec-2025 Corporate Asset Purchase Buildings and Property
Joint Venture (Chinese Partners / GenOway) 17-Oct-2023 Joint Venture Distributors (Healthcare)
Merck (Worldwide Rights on Foundational CRISPR/Cas9 Portfolio) 01-Dec-2018 Corporate Asset Purchase Buildings and Property
Axenis 06-Sep-2018 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Bluebird Bio (RMCE Technology Global License) 12-Jul-2011 Merger/Acquisition Biotechnology
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

GenOway ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view GenOway’s complete esg history, request access »

GenOway FAQs

  • When was GenOway founded?

    GenOway was founded in 1999.

  • Where is GenOway headquartered?

    GenOway is headquartered in Lyon, France.

  • What is the size of GenOway?

    GenOway has 163 total employees.

  • What industry is GenOway in?

    GenOway’s primary industry is Biotechnology.

  • Is GenOway a private or public company?

    GenOway is a Public company.

  • What is GenOway’s stock symbol?

    The ticker symbol for GenOway is ALGEN.

  • What is the current stock price of GenOway?

    As of 20-Nov-2026 the stock price of GenOway is $2.09.

  • What is the current market cap of GenOway?

    The current market capitalization of GenOway is $25.8M.

  • What is GenOway’s current revenue?

    The trailing twelve month revenue for GenOway is $23.1M.

  • Who are GenOway’s competitors?

    Celprogen, Genetix Biotherapeutics, Premas Biotech, GemPharmatech, and Lake Immunogenics are some of the 32 competitors of GenOway.

  • What is GenOway’s annual earnings per share (EPS)?

    GenOway’s EPS for 12 months was -$0.17.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process